The pitfalls of mass hospital health care worker testing for COVID-19.

IF 1.1 Q3 Medicine JAMMI Pub Date : 2020-10-11 eCollection Date: 2020-10-01 DOI:10.3138/jammi-2020-06-17
Dominik Mertz, Gerald A Evans, Susy Hota
{"title":"The pitfalls of mass hospital health care worker testing for COVID-19.","authors":"Dominik Mertz, Gerald A Evans, Susy Hota","doi":"10.3138/jammi-2020-06-17","DOIUrl":null,"url":null,"abstract":"On May 29, 2020, Ontario released an ambitious plan, “Protecting Ontarians through Enhanced Testing,” [1] for COVID-19. The approach included testing asymptomatic individuals who are at risk for infection due to suspected exposure or at-risk occupations and targeted testing campaigns for high-risk populations. Shortly thereafter, several Ontario hospitals were requested to conduct comprehensive health care worker (HCW) asymptomatic testing for COVID-19. While on the surface, broad testing of HCWs for COVID-19 seems to have merit, a deeper look raises questions regarding the rationale, effectiveness, and potential harms of this endeavour. To understand the rationale for targeting hospital HCWs for mass, asymptomatic testing, we must first ask what question we seek to answer by carrying out this testing. If the goal is to derive an estimate of community prevalence of COVID-19, hospital HCWs may or may not be representative of the general public. As a result, are we asserting that HCWs are at extremely high risk for acquiring COVID-19 despite personal protective equipment (PPE) use and are therefore driving community transmission? Studies to date have not suggested a significantly higher incidence of COVID-19 infection in acute hospital HCWs compared to the community, outside of outbreak settings [2–4]. Indiscriminate testing of asymptomatic HCWs is challenging to interpret. When asymptomatic persons test positive for COVID-19, we identify four groups with differing levels of infectious risk. In descending order, they are [1] those who are pre-symptomatic, [2] those who have a completely asymptomatic course of infection, [3] those who are recovering from infection, and [4] those with a false-positive test result. While pre-symptomatic individuals are likely as infectious as symptomatic individuals, this group will be a small minority of the true positive cases given that our current polymerase chain Dominik Mertz MD, MSc1, Gerald A Evans MD2, Susy Hota MD, MSc3 on behalf of the Ontario Infection Prevention and Control Community of Practice (see list) 1Hamilton Health Sciences Centre & McMaster University, Hamilton, Ontario; 2Kingston Health Sciences Centre & Queen’s University, Kingston, Ontario; 3University Health Network & University of Toronto, Toronto, Ontario","PeriodicalId":36782,"journal":{"name":"JAMMI","volume":" ","pages":"121-123"},"PeriodicalIF":1.1000,"publicationDate":"2020-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608737/pdf/jammi-2020-06-17.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMMI","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3138/jammi-2020-06-17","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/10/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

On May 29, 2020, Ontario released an ambitious plan, “Protecting Ontarians through Enhanced Testing,” [1] for COVID-19. The approach included testing asymptomatic individuals who are at risk for infection due to suspected exposure or at-risk occupations and targeted testing campaigns for high-risk populations. Shortly thereafter, several Ontario hospitals were requested to conduct comprehensive health care worker (HCW) asymptomatic testing for COVID-19. While on the surface, broad testing of HCWs for COVID-19 seems to have merit, a deeper look raises questions regarding the rationale, effectiveness, and potential harms of this endeavour. To understand the rationale for targeting hospital HCWs for mass, asymptomatic testing, we must first ask what question we seek to answer by carrying out this testing. If the goal is to derive an estimate of community prevalence of COVID-19, hospital HCWs may or may not be representative of the general public. As a result, are we asserting that HCWs are at extremely high risk for acquiring COVID-19 despite personal protective equipment (PPE) use and are therefore driving community transmission? Studies to date have not suggested a significantly higher incidence of COVID-19 infection in acute hospital HCWs compared to the community, outside of outbreak settings [2–4]. Indiscriminate testing of asymptomatic HCWs is challenging to interpret. When asymptomatic persons test positive for COVID-19, we identify four groups with differing levels of infectious risk. In descending order, they are [1] those who are pre-symptomatic, [2] those who have a completely asymptomatic course of infection, [3] those who are recovering from infection, and [4] those with a false-positive test result. While pre-symptomatic individuals are likely as infectious as symptomatic individuals, this group will be a small minority of the true positive cases given that our current polymerase chain Dominik Mertz MD, MSc1, Gerald A Evans MD2, Susy Hota MD, MSc3 on behalf of the Ontario Infection Prevention and Control Community of Practice (see list) 1Hamilton Health Sciences Centre & McMaster University, Hamilton, Ontario; 2Kingston Health Sciences Centre & Queen’s University, Kingston, Ontario; 3University Health Network & University of Toronto, Toronto, Ontario
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
大规模医院卫生保健工作者COVID-19检测的陷阱。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
JAMMI
JAMMI Medicine-Infectious Diseases
CiteScore
3.80
自引率
0.00%
发文量
48
期刊最新文献
Whipple's disease in southern New Brunswick, Canada: A case series. Using routine asymptomatic Clostridioides difficile testing to identify patients at high risk of developing C. difficile infection during hematopoietic cell transplantation. Canada-wide bloodstream infectious diseases surveillance: Quantum leap or a baby step toward a comprehensive electronic national infections surveillance system? Congenital measles: A rare but life-threatening consequence of Canada's largest measles outbreak. Oxacillin-susceptible methicillin-resistant Staphylococcus aureus septic bursitis identified following clinical failure with β-lactam therapy: A case report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1